2026 RNDS | Day Two Kickoff: Quality of Life as a Clinical Outcome @wearesrna
2026 RNDS | Day Two Kickoff: Quality of Life as a Clinical Outcome  @wearesrna
Uploaded October 2026 | Updated November 2026, 3 hours ago
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Carlos A. Pardo, MD, of Johns Hopkins University opened day two by explaining that the morning would focus on how people living with rare neuroimmune disorders can recover and keep doing what matters to them, rather than on spinal cord imaging, antibodies, or diagnostic criteria [00:00:35]. He noted that treatments such as plasma exchange, IV methylprednisolone, rituximab, and Ocrevus calm the immune system and help control progression, and that the harder question is how to continue a full, happy life afterward [00:01:24]. Dr. Pardo shared the "vitamin P" (positivity) and "vitamin O" he tells the people he treats are an important part of recovery after a diagnosis such as myelitis [00:02:10]. He described quality of life as a personal idea, from dancing with a daughter to watching a child's games, and asked what each person hopes to accomplish through rehabilitation [00:03:27]. He then ran two live audience polls, one on what has helped people feel supported and connected at RNDS and one on how people like to recharge after a full day [00:04:32].

Carlos A. Pardo, MD, is a Professor of Neurology and Pathology in the Division of Neuroimmunology and Neuroinfectious Disorders at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Director of the Johns Hopkins Myelitis and Myelopathy Center. He is the principal investigator of the Neuroimmunopathology Laboratory, a member of the HIV Neurosciences Research Group, and a clinical neurologist at the Multiple Sclerosis and Transverse Myelitis Centers at Johns Hopkins Hospital. His clinical specialization is neuroimmunological and infectious disorders of the nervous system, with particular focus on multiple sclerosis, transverse myelitis, neurosarcoidosis, and neurological complications of autoimmune disorders.

00:00 Good Morning and Welcome Back
00:35 Focus for Day Two
01:24 Treatments and Recovery
02:10 Vitamin P and Vitamin O
03:27 What Quality of Life Means
04:04 Audience Poll on Feeling Supported
05:00 People and Conversation at RNDS
05:39 Audience Poll on Recharging
2026 RNDS | Day Two Kickoff: Quality of Life as a Clinical Outcome201. Steroid Dependence2024 RNDS | What’s my Diagnosis? Physician Panel Discussion Based on Community Panel Presentations2024 RNDS | Adaptive Tools and Resources2025 RNDS en Español | Manejo de síntomas2025 RNDS | Understanding diagnosis of rare diseases: ADEM, AFM, MOGAD, NMOSD, ON, and TMThe Power of Community: Alan2025 RNDS | Making the Switch: How to Know if Your Long-Term Treatment is Right for You2025 RNDS | Panel: Is it a relapse or recurrence? Deliberations on acute and long-term treatment2024 RNDS | Fatigue and Rare Neuroimmune Disorders2023 RNDS en Español | Entendiendo los ensayos clínicos en NMOSD y MOGADThe Power of Community: Amber
SRNA |

2026 RNDS | Day Two Kickoff: Quality of Life as a Clinical Outcome

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER